ARTICLE | Clinical News
Xeloda capecitabine regulatory update
August 15, 2011 7:00 AM UTC
The Scottish Medicines Consortium recommended the use of Xeloda capecitabine from Roche on the National Health Service (NHS) in Scotland for the adjuvant treatment of stage III colon cancer following ...